{"id":51422,"date":"2022-11-30T23:02:18","date_gmt":"2022-11-30T22:02:18","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\/"},"modified":"2022-11-30T23:02:18","modified_gmt":"2022-11-30T22:02:18","slug":"exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\/","title":{"rendered":"Exelixis to Present at the Virtual JMP Securities Hematology and Oncology Summit on December 7, 2022"},"content":{"rendered":"
\n

\n– Presentation to be webcast on <\/i>www.exelixis.com<\/i><\/a> –<\/i>\n<\/p>\n

ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in a fireside chat at the virtual JMP Securities Hematology and Oncology Summit on Wednesday, December 7, 2022 at 12:00 pm ET \/ 9:00 am PT.\n<\/p>\n

<\/a><\/p>\n

\nTo access the webcast link, log onto www.exelixis.com<\/a> and proceed to the News & Events \/ Event Calendar page under the Investors & Media heading. Please connect to the company\u2019s website at least 15 minutes prior to the presentation to ensure adequate time for any software download that may be required to listen to the webcast. A replay will also be available at the same location for at least 30 days.\n<\/p>\n

\nAbout Exelixis<\/b>\n<\/p>\n

\nFounded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Following early work in model system genetics, we established a broad drug discovery and development platform that has served as the foundation for our continued efforts to bring new cancer therapies to patients in need. Our discovery efforts have resulted in four commercially available products, CABOMETYX\u00ae<\/sup> (cabozantinib), COMETRIQ\u00ae<\/sup> (cabozantinib), COTELLIC\u00ae<\/sup> (cobimetinib) and MINNEBRO\u00ae<\/sup> (esaxerenone), and we have entered into partnerships with leading pharmaceutical companies to bring these important medicines to patients worldwide. Supported by revenues from our marketed products and collaborations, we are committed to prudently reinvesting in our business to maximize the potential of our pipeline. We are supplementing our existing therapeutic assets with targeted business development activities and internal drug discovery \u2013 all to deliver the next generation of Exelixis medicines and help patients recover stronger and live longer. Exelixis is a member of the Standard & Poor\u2019s (S&P) MidCap 400 index, which measures the performance of profitable mid-sized companies. For more information about Exelixis, please visit www.exelixis.com<\/a>, follow @ExelixisInc<\/a> on Twitter or like Exelixis, Inc.<\/a> on Facebook.\n<\/p>\n

\nExelixis, the Exelixis logo, CABOMETYX, COMETRIQ and COTELLIC are registered U.S. trademarks. MINNEBRO is a registered Japanese trademark.<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestors Contact:<\/b>
Varant Shirvanian<\/i>
Associate Director, Investor Relations<\/i>
Exelixis, Inc.<\/i>
650-837-7917<\/i>
vshirvanian@exelixis.com<\/i><\/a><\/p>\n

Media Contact:<\/b>
Hal Mackins<\/i>
For Exelixis, Inc.<\/i>
415-994-0040<\/i>
hal@torchcommunications.com<\/i><\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

– Presentation to be webcast on www.exelixis.com – ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in a fireside chat at the virtual JMP Securities Hematology and Oncology Summit on Wednesday, December 7, 2022 at 12:00 pm ET \/ 9:00 am PT. To access the webcast link, log onto www.exelixis.com … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-51422","format-standard","category-industry"],"yoast_head":"\nExelixis to Present at the Virtual JMP Securities Hematology and Oncology Summit on December 7, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exelixis to Present at the Virtual JMP Securities Hematology and Oncology Summit on December 7, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"– Presentation to be webcast on www.exelixis.com – ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in a fireside chat at the virtual JMP Securities Hematology and Oncology Summit on Wednesday, December 7, 2022 at 12:00 pm ET \/ 9:00 am PT. To access the webcast link, log onto www.exelixis.com ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-30T22:02:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221130005992\/en\/610803\/21\/exelixis_id_rgb_2c.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Exelixis to Present at the Virtual JMP Securities Hematology and Oncology Summit on December 7, 2022\",\"datePublished\":\"2022-11-30T22:02:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\\\/\"},\"wordCount\":382,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221130005992\\\/en\\\/610803\\\/21\\\/exelixis_id_rgb_2c.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\\\/\",\"name\":\"Exelixis to Present at the Virtual JMP Securities Hematology and Oncology Summit on December 7, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221130005992\\\/en\\\/610803\\\/21\\\/exelixis_id_rgb_2c.jpg\",\"datePublished\":\"2022-11-30T22:02:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221130005992\\\/en\\\/610803\\\/21\\\/exelixis_id_rgb_2c.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221130005992\\\/en\\\/610803\\\/21\\\/exelixis_id_rgb_2c.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exelixis to Present at the Virtual JMP Securities Hematology and Oncology Summit on December 7, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exelixis to Present at the Virtual JMP Securities Hematology and Oncology Summit on December 7, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\/","og_locale":"en_US","og_type":"article","og_title":"Exelixis to Present at the Virtual JMP Securities Hematology and Oncology Summit on December 7, 2022 - Pharma Trend","og_description":"– Presentation to be webcast on www.exelixis.com – ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in a fireside chat at the virtual JMP Securities Hematology and Oncology Summit on Wednesday, December 7, 2022 at 12:00 pm ET \/ 9:00 am PT. To access the webcast link, log onto www.exelixis.com ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-30T22:02:18+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221130005992\/en\/610803\/21\/exelixis_id_rgb_2c.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Exelixis to Present at the Virtual JMP Securities Hematology and Oncology Summit on December 7, 2022","datePublished":"2022-11-30T22:02:18+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\/"},"wordCount":382,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221130005992\/en\/610803\/21\/exelixis_id_rgb_2c.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\/","url":"https:\/\/pharma-trend.com\/en\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\/","name":"Exelixis to Present at the Virtual JMP Securities Hematology and Oncology Summit on December 7, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221130005992\/en\/610803\/21\/exelixis_id_rgb_2c.jpg","datePublished":"2022-11-30T22:02:18+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221130005992\/en\/610803\/21\/exelixis_id_rgb_2c.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221130005992\/en\/610803\/21\/exelixis_id_rgb_2c.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Exelixis to Present at the Virtual JMP Securities Hematology and Oncology Summit on December 7, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51422","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51422"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51422\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51422"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51422"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51422"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}